Authors:
De Bernardi, B
Pianca, C
Pistamiglio, P
Veneselli, E
Viscardi, E
Pession, A
Alvisi, P
Carli, M
Donfrancesco, A
Casale, F
Giuliano, MG
di Montezemolo, LC
Di Cataldo, A
Lo Curto, M
Bagnulo, S
Schumacher, RF
Tamburini, A
Garaventa, A
Clemente, L
Bruzzi, P
Citation: B. De Bernardi et al., Neuroblastoma with symptomatic spinal cord compression at diagnosis: Treatment and results with 76 cases, J CL ONCOL, 19(1), 2001, pp. 183-190
Authors:
Miano, M
Garaventa, A
Pizzitola, MR
Lo Piccolo, MS
Dallorso, S
Villavecchia, GP
Bertolazzi, C
Cabria, M
De Bernardi, B
Citation: M. Miano et al., Megatherapy combining I-131 metaiodobenzylguanidine and high-dose chemotherapy with haematopoietic progenitor cell rescue for neuroblastoma, BONE MAR TR, 27(6), 2001, pp. 571-574
Authors:
Rossi, GA
Castagnola, E
Viscardi, E
Gambini, C
Occhi, M
Granata, C
Franzone, P
De Bernardi, B
Citation: Ga. Rossi et al., Bronchiolitis obliterans organizing pneumonia. An early complication of therapy for Hodgkin's disease, INT J PED H, 6(5), 2000, pp. 339-345
Authors:
Casanova, M
Ferrari, A
Bisogno, G
Cecchetto, G
Basso, E
De Bernardi, B
Indolfi, P
Bellani, FF
Carli, M
Citation: M. Casanova et al., Alveolar soft part sarcoma in children and adolescents: A report from the Soft-Tissue Sarcoma Italian Cooperative Group, ANN ONCOL, 11(11), 2000, pp. 1445-1449
Authors:
Faulkner, LB
Garaventa, A
Paoli, A
Tintori, V
Tamburini, A
Lacitignola, L
Veltroni, M
Lo Piccolo, MS
Viscardi, E
Milanaccio, C
Tondo, A
Spinelli, S
Bernini, G
De Bernardi, B
Citation: Lb. Faulkner et al., In vivo cytoreduction studies and cell sorting-enhanced tumor-cell detection in high-risk neuroblastoma patients: Implications for leukapheresis strategies, J CL ONCOL, 18(22), 2000, pp. 3829-3836
Authors:
Granata, C
Fagnani, AM
Gambini, C
Beglino, C
Bagnulo, S
Cecchetto, G
Federici, S
Inserra, A
Michelazzi, A
Riccipetitoni, G
Rizzo, A
Tamaro, P
Jasonni, V
De Bernardi, B
Citation: C. Granata et al., Features and outcome of neuroblastoma detected before birth, J PED SURG, 35(1), 2000, pp. 88-91
Authors:
Raggi, CC
Maggi, M
Renzi, D
Calabro, A
Bagnoni, ML
Scaruffi, P
Tonini, GP
Pazzagli, M
De Bernardi, B
Bernini, G
Serio, M
Orlando, C
Citation: Cc. Raggi et al., Quantitative determination of sst2 gene expression in neuroblastoma tumor predicts patient outcome, J CLIN END, 85(10), 2000, pp. 3866-3873
Authors:
Lo Cunsolo, C
Iolascon, A
Cavazzana, A
Cusano, R
Strigini, P
Mazzocco, K
Giordani, L
Massimo, L
De Bernardi, B
Conte, M
Tonini, GP
Citation: C. Lo Cunsolo et al., Neuroblastoma in two siblings supports the role of 1p36 deletion in tumor development, CANC GENET, 109(2), 1999, pp. 126-130
Authors:
Raggi, CC
Bagnoni, ML
Tonini, GP
Maggi, M
Vona, G
Pinzani, P
Mazzocco, K
De Bernardi, B
Pazzagli, M
Orlando, C
Citation: Cc. Raggi et al., Real-time quantitative PCR for the measurement of MYCN amplification in human neuroblastoma with the TaqMan detection system, CLIN CHEM, 45(11), 1999, pp. 1918-1924
Authors:
Raschella, G
Cesi, V
Amendola, R
Negroni, A
Tanno, B
Altavista, P
Tonini, GP
De Bernardi, B
Calabretta, B
Citation: G. Raschella et al., Expression of B-myb in neuroblastoma tumors is a poor prognostic factor independent from MYCN amplification, CANCER RES, 59(14), 1999, pp. 3365-3368
Authors:
Garaventa, A
Bellagamba, O
Lo Piccolo, MS
Milanaccio, C
Lanino, E
Bertolazzi, L
Villavecchia, GP
Cabria, M
Scopinaro, G
Claudiani, F
De Bernardi, B
Citation: A. Garaventa et al., I-131-metaiodobenzylguanidine (I-131-MIBG) therapy for residual neuroblastoma: a mono-institutional experience with 43 patients, BR J CANC, 81(8), 1999, pp. 1378-1384